Refine by
Tumor Cells Articles & Analysis: This-Year
2 news found
Research on molecular targeted therapy for tumors is increasing, and new targeted therapeutic agents are emerging. ...
ACE program participation is offered exclusively to academic institutions and provides access to the POAI proprietary active ML/AI and biobank of primary patient dissociated tumor cells (DTCs) at no-cost, with data and IP protection provided to participants. ...